Spyre Therapeutics (SYRE)

• Market cap: $2.58B
• 1 day: 1.65%
• 5 days: -0.48%
• 1 month: 11.11%
• 3 months: 39.99%
• 6 months: 106%
• Year to date: 8.86%
• 1 year: 45.37%
• 5 years: -82.84%
• 10 years: -86.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Employees: 95